A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome.
about
Nonmyeloablative allogeneic stem cell transplantation for non-hodgkin lymphomaTreatment of peripheral T-cell lymphoma: are we data driven or driving the data?Gamma-delta t-cell lymphomas.Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphomaLong-term survival in patients with peripheral T-cell non-Hodgkin lymphomas after allogeneic hematopoietic stem cell transplant.Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndromeTreatment of High-Risk T-NHL with Stem Cell Transplantation: A Single Center Experience.Skin Recurrence of Transformed Mycosis Fungoides Postumbilical Cord Blood Transplant despite Complete Donor Chimerism.Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease.New developments in the treatment of peripheral T-cell lymphoma - role of Belinostat.How I treat the peripheral T-cell lymphomasAnti-thymocyte globulin could improve the outcome of allogeneic hematopoietic stem cell transplantation in patients with highly aggressive T-cell tumorsA disease risk index for patients undergoing allogeneic stem cell transplantation.NK/T-cell lymphomas in childrenHematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curve.Allogeneic hematopoietic stem cell transplantation in mycosis fungoides.Current status of allogeneic transplantation for aggressive non-Hodgkin lymphoma.Update: peripheral T-cell lymphomas.The utility of bexarotene in mycosis fungoides and Sézary syndrome.Investigational drugs for T-cell lymphoma.How I manage peripheral T-cell lymphoma, not otherwise specified and angioimmunoblastic T-cell lymphoma: current practice and a glimpse into the future.Is myeloablative dose intensity necessary in allogeneic hematopoietic cell transplantation for lymphomas?Treatment approaches of hard-to-treat non-Hodgkin lymphomas.The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.A prospective cohort study of patients with peripheral T-cell lymphoma in the United States.Effect of immune modulation in relapsed peripheral T-cell lymphomas after post-allogeneic stem cell transplantation: a study by the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.Peripheral T-cell Lymphomas: Updates in Allogeneic Hematopoietic Stem Cell Transplantation
P2860
Q26999011-4C7D8EA8-0517-4B24-ABAA-D40236C7BE55Q30613674-BD705014-3453-4D11-921B-3E0992323BD0Q33417290-E2EFD9A8-5779-4346-AB62-CCCDCB4F66FCQ33608520-19F0D853-FB8B-4BDE-A1A6-7BD1D5D47C42Q33745878-50F79AE5-B10B-41D7-9C08-4ED88811B427Q34459010-93B433BE-828F-44D7-9077-B30B233B6B43Q34766846-3CE2C35F-CC4A-462E-BB8A-DB2CCB6A4B80Q34785645-AA08983D-8704-490E-91A0-F4636CE4A7B4Q35533531-81939372-4029-4507-A5B1-0F791D081953Q35703714-17CE0FE6-44DD-4A68-8590-2BB7759ABA7EQ35865090-B75F9180-DCCA-4E2C-BB1C-21A3E6DA2D15Q35921888-52C3A18D-C33E-4527-B31E-3FA6AD32456EQ36141944-93F99E61-C9A2-4E9F-99B7-C690BDD47F22Q36995625-A6FCF487-8BBA-48DC-95F2-C016564D1830Q37122302-71B5566F-C15C-4ACE-ACAC-DC5D19E20D64Q37391571-7F30D1B8-AE3C-43F7-8098-334550CE80F3Q37420625-0F623665-F381-4D0F-9FE9-5C4BAD5B9984Q37938531-5AE68691-5205-4956-9C48-D84C5BE31448Q37939715-CA76C797-B9BD-41EA-A97D-1A8EA2050C60Q38354440-5BA34A70-5B19-4793-A04A-CFC5B48140D0Q38635909-FF8C2866-B46A-457B-BB7E-7C35BFD0B339Q38782072-7D3CE19F-36FF-49E1-A0CE-868F1143008EQ38860997-FF370D7E-038B-477F-81E2-937A7357508CQ39091822-A1F2CB4C-BEC1-4239-8548-CC836651DD0DQ40421573-CE15BA1A-385A-41B3-9210-9321AF23951BQ40444551-F191FA7F-7740-4A6D-9F2D-76315139C859Q41106212-9AFBCD57-F201-47C0-8EF2-1DCDA28902BDQ50790069-B29AE3FF-5A7C-4DE7-B881-C69C09A307C6Q58763961-24720632-0E6B-4A56-8F9E-6C5FAC641242
P2860
A large single-center experience with allogeneic stem-cell transplantation for peripheral T-cell non-Hodgkin lymphoma and advanced mycosis fungoides/Sezary syndrome.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
A large single-center experien ...... sis fungoides/Sezary syndrome.
@ast
A large single-center experien ...... sis fungoides/Sezary syndrome.
@en
type
label
A large single-center experien ...... sis fungoides/Sezary syndrome.
@ast
A large single-center experien ...... sis fungoides/Sezary syndrome.
@en
prefLabel
A large single-center experien ...... sis fungoides/Sezary syndrome.
@ast
A large single-center experien ...... sis fungoides/Sezary syndrome.
@en
P2093
P2860
P356
P1433
P1476
A large single-center experien ...... sis fungoides/Sezary syndrome.
@en
P2093
A S Freedman
C S Cutler
D C Fisher
E D Jacobsen
R J Soiffer
P2860
P304
P356
10.1093/ANNONC/MDQ698
P577
2011-01-20T00:00:00Z